SCHEMBL18136307

SCHEMBL18136307

c1cc(N2CCCCC2)cnn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.56
MAPT P10636 5/20 0.43
HRH4 Q9H3N8 1/20 0.42
ALDH1A1 P00352 6/20 0.42
ALOX15 P16050 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.42
GAA P10253 2/20 0.42
HTT P42858 2/20 0.42
KMT2A Q03164 2/20 0.42
NPC1 O15118 1/20 0.42
USP2 O75604 1/20 0.42
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42
THRB P10828 1/20 0.42
RECQL P46063 1/20 0.42
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10491585 1.00 CHKA (0.56) CHKAMAPTHRH4ALDH1A1ALOX15
SCHEMBL11922650 0.98 CHKA (0.58) CHKAMAPTHRH4ALDH1A1ALOX15
SCHEMBL30837612 0.98 CHKA (0.58) CHKAMAPTHRH4ALDH1A1ALOX15
SCHEMBL30750948 0.93 CHKA (0.52) CHKAMAPTHRH4CHRNB2CHRNA4
SCHEMBL18136308 0.81 HRH4 (0.50) CHKAMAPTHRH4ALDH1A1KDM4E
SCHEMBL2103156 0.81 CHKA (0.39) CHKAMAPTCHRNB2CHRNA4LMNA
SCHEMBL194631 0.79 PLD1 (0.62) CHRNB2CHRNA4
SCHEMBL9557411 0.79 CHKA (0.38) CHKAMAPTHRH4ALDH1A1CHRNB2
SCHEMBL18136305 0.79 LMNA (0.50) CHKAMAPTALDH1A1ALOX15KDM4E
SCHEMBL9557417 0.79 HRH4 (0.47) MAPTHRH4ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250275952-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS MYOKARDIA INC (US) 2025-09-04 US disclosed
US-20220117955-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS MyoKardia, Inc. 2022-04-21 US disclosed
US-9469706-B2 Polymers functionalized with unsaturated heterocycles containing a protected amino group BRIDGESTONE CORPORATION (JP) 2016-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275952-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS TNNI3, UMPS, TNNT2 CHKA 2417/4885MAPT 1759/4885HRH4 1185/4885
US-20220117955-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS TNNI3, UMPS, TNNT2 CHKA 2417/4885MAPT 1759/4885HRH4 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.